Drug Information Analysis Service

Abstract

Get full access to this article

View all access options for this article.

References

Solomon

Steel

Spaccavento

. Verapamil prophylaxis of migraine: A double-blind, placebo-controlled study. JAMA 1983; 250: 2500–2.

Edmeads

. Cerebral blood flow in migraine. Headache 1977; 17: 148–52.

Schuler

Goldman

Munger

. The role of calcium channel blocking agents in the prevention of migraine. Drug Intell Clin Pharm 1988; 22: 187–91.

Welch

Chabi

Nell

Biochemical comparison of migraine and stroke. Headache 1976; 16: 160–7.

McGoon

Vleistra

Holmes

Osborn

. The clinical use of verapamil. Mayo Clin Proc 1982; 57: 495–510.

Ad Hoc Committee on Headache, classification of headache. JAMA 1962; 179: 717–8.

Markely

Cheronix

JCD

Piepho

. Verapamil in prophylactic therapy of migraine. Neurology 1984; 34: 973–6.

Asbury

Fields

. Pain due to peripheral nerve damage: An hypothesis. Neurology 1984; 34: 1587–90.

Moragas

Kierland

. The outcome of patients with herpes zoster. Arch Dermatol 1957; 75: 193–6.

10.

Watson

CPN

Evans

Watt

Birkett

. Post-herpetic neuralgia: 208 cases. Pain 1988; 35: 289–97.

11.

Portenoy

Duma

Foley

. Acute herpetic and post-herpetic neuralgia: Clinical review and current management. Ann Neurol 1986; 20: 651–64.

12.

Yaksh

. Central and peripheral mechanisms for the antianalgesic action of acetylsalicylic acid. In: Bamett

HJM

Hirsh

Mustard

JFM

, eds. Acetylsalicylic acid: New uses for an old drug. New York: Raven Press, 1982: 137–51.

13.

Siegel

McConnell

Porter

Aspirin-like drugs inhibit arachidonic acid metabolism via lipoxygenase and cyclo-oxygenase in rat neutrophils from carrageenan pleural exudates. Biochem Biophys Res Commun 1980; 92: 688–95.

14.

Woodforde

Dwyer

McEwen

Treatment of postherpetic neuralgia. Med J Aust 1965; 2: 869–72.

15.

Amadio

Cummings

Amadio

. A framework for management of chronic pain. Am Fam Physician 1988; 38: 155–60.

16.

Rabinowitz

Feldman

Weinberger

Schumacher

. Comparative tissue absorption of oral ¹⁴C-aspirin and topical triethanolamine ¹⁴C-salicylate in human and canine knee joints. J Clin Pharmacol 1982; 22: 42–8.

17.

Feldmann

Maibach

. Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970; 54: 399–404.

18.

Lublanezki

Cleary

. External analgesic products. In: Davidson

, ed. Handbook of nonprescription drugs. 8th ed. Washington, DC: American Pharmaceutical Association, 1986: 547–56.

19.

Robertson

Maibach

. Dermatologic pharmacology. In: Katzung

, ed. Basic and clinical pharmacology. 3rd ed. Norwalk, CT: Appleton and Lange, 1987: 764–80.

20.

Flynn

. Topical drug absorption and topical pharmaceutical systems. In: Banker

Rhodes

, eds. Modern pharmaceutics. New York: Marcel Dekker, 1979: 263–327.

21.

Levy

. Clinical pharmacokinetics of aspirin. Pediatrics 1978; 62: 867–72.

22.

Lowenthal

. Drug therapy in the elderly: Special considerations. Geriatrics 1987; 42: 77–82.

23.

Lindsey

. Two cases of fatal salicylate poisoning after topical application of an antifungal solution. Med J Aust 1968; 1: 353–4.

24.

King

. Concerning the management of pain associated with herpes zoster and of post-herpetic neuralgia. Pain 1988; 33: 73–8.

25.

Kassirer

. King and Robert, concerning the management of pain associated with herpes zoster and post-herpetic neuralgia (letter). Pain 1988; 35: 368–9.

26.

Acland

. A new shingles therapy (letter). N Z Med J 1988; 101: 3.

27.

Beecher

. The powerful placebo. JAMA 1955; 159: 1602–6.

28.

Houston

. The doctor himself as a therapeutic agent. Ann Intern Med 1938; 11: 1416–25.

29.

Liberman

. An analysis of the placebo phenomenon. J Chronic Dis 1962; 15: 761–83.

30.

Egbert

Battit

Welch

Bartlett

. Reduction of postoperative pain by encouragement and instruction of patients: A study of doctor-patient rapport. N Engl J Med 1964; 270: 825–7.

31.

Windholz

, ed. Merck index. 10th ed. Rahway, NJ: Merck, 1983: 123.

32.

Trevor

Miller

. General anesthetics. In: Katzunj

, ed. Basic and clinical pharmacology. 3rd ed. Norwalk, CT: Appleton and Lange, 1987: 279–88.

33.

Woodhouse

Wynne

. Age related changes in liver size and hepatic blood flow: The influence on drug metabolism in the elderly. Clin Pharmacokinet 1988; 15: 287–94.

34.

Fink

. Meduna and the origins of convulsive therapy. Am J Psychiatry 1984; 141: 1034–41.

35.

Coffey

Weiner

. Electroconvulsive therapy: An update. Hosp Community Psychiatry 1990; 41: 515–21.

36.

Lancaster

Steinert

Frost

. Unilateral electroconvulsive therapy. J Ment Sci 1958; 104: 221–7.

37.

Squire

Slater

. Bilateral and unilateral ECT: Effects on verbal and non-verbal memory. Am J Psychiatry 1978; 135: 1316–20.

38.

Sackeim

Decina

Kanzler

Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987; 144: 1449–55.

39.

Robin

De Tissera

. A double-blind controlled comparison of the therapeutic effects of low and high energy electroconvulsive therapies. Br J Psychiatry 1982; 141: 357–66.

40.

Miller

Faber

Hatch

Alexander

. Factors affecting amnesia, seizure duration, and efficacy in ECT. Am J Psychiatry 1985; 142: 692–6.

41.

Abrams

. A hypothesis to explain divergent findings among studies comparing the efficacy of unilateral and bilateral ECT in depression. Convulsive Ther 1986; 2: 253–7.

42.

Fink

. New technology in convulsive therapy: A challenge in training. Am J Psychiatry 1987; 144: 1195–8.

43.

Fink

. Convulsive therapy: theory and practice. New York: Raven Press, 1979.

44.

Sackeim

Decina

Prohovnik

Malitz

. Seizure threshold in electroconvulsive therapy: Effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry 1987; 44: 355–60.

45.

Newman

Zohar

Kalian

Belmaker

. The effects of chronic lithium and ECT on A₁ and A₂ adenosine receptor systems in rat brain. Brain Res 1984; 291: 188–92.

46.

Dunwiddie

Worth

. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 1982; 220: 70–6.

47.

Shapira

Zohar

Newman

Drexler

Belmaker

. Potentiation of seizure length and clinical response to electroconvulsive therapy by caffeine pretreatment: A case report. Convulsive Ther 1985; 1: 58–60.

48.

Hinkle

Coffey

Weiner

Cress

Christison

. Use of caffeine to lengthen seizures in ECT. Am J Psychiatry 1987; 144: 1143–8.

49.

Shapira

Lerer

Gilboa

Drexler

Kugelmass

Calev

. Facilitation of ECT by caffeine pretreatment. Am J Psychiatry 1987; 144: 1199–202.

50.

Acevedo

Smith

. Adverse reaction to use of caffeine in ECT (letter). Am J Psychiatry 1988; 145: 529–30.

51.

Lurie

Coffey

. Caffeine-modified electroconvulsive therapy in depressed patients with medical illness. J Clin Psychiatry 1990; 51: 154–7.

52.

Coffey

Weiner

Hinkle

Cress

Daughtry

Wilson

. Augmentation of ECT seizures with caffeine. Biol Psychiatry 1987; 22: 637–49.

53.

Coffey

Figiel

Weiner

Saunders

. Caffeine augmentation of ECT. Am J Psychiatry 1990; 147: 579–85.